2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …

…, KM Olsson, J Pepke-Zaba, JK Quint… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Defining the relationship between COPD and CVD: what are the implications for clinical practice?

AD Morgan, R Zakeri, JK Quint - Therapeutic advances in …, 2018 - journals.sagepub.com
Cardiovascular diseases (CVDs) are arguably the most important comorbidities in chronic
obstructive pulmonary disease (COPD). CVDs are common in people with COPD, and their …

[HTML][HTML] The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

…, L Daines, K Poinasamy, JK Quint… - The Lancet …, 2021 - thelancet.com
Persistent ill health after acute COVID-19—referred to as long COVID, the post-acute COVID-
19 syndrome, or the post-COVID-19 condition—has emerged as a major concern. We …

Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study

JK Quint, ERC Millett, M Joshi… - European …, 2016 - Eur Respiratory Soc
There is a paucity of data on incidence, prevalence and mortality associated with non-cystic
fibrosis bronchiectasis. Using the Clinical Practice Research Datalink for participants …

[HTML][HTML] Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study

…, SL Cadogan, L Smeeth, JF Hayes, JK Quint… - The Lancet Digital …, 2021 - thelancet.com
Background There are concerns that the response to the COVID-19 pandemic in the UK
might have worsened physical and mental health, and reduced use of health services …

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

…, KM Olsson, J Pepke-Zaba, JK Quint… - European …, 2023 - Eur Respiratory Soc
Guidelines summarize and evaluate available evidence, with the aim of assisting health
professionals in proposing the best management strategies for an individual patient with a …

Defective macrophage phagocytosis of bacteria in COPD

AE Taylor, TK Finney-Hayward, JK Quint… - European …, 2010 - Eur Respiratory Soc
Exacerbations of chronic obstructive pulmonary disease (COPD) are an increasing cause of
hospitalisations and are associated with accelerated progression of airflow obstruction …

Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study

…, AB Docherty, EM Harrison, JK Quint… - American journal of …, 2020 - atsjournals.org
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …

Temporal clustering of exacerbations in chronic obstructive pulmonary disease

JR Hurst, GC Donaldson, JK Quint… - American journal of …, 2009 - atsjournals.org
Rationale: Exacerbations are important events in chronic obstructive pulmonary disease.
Preventing exacerbations is a key treatment goal. Observational data suggest that after a …

[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

…, L Howard, DG Wootton, S Dunachie, JK Quint… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward …